trending Market Intelligence /marketintelligence/en/news-insights/trending/uyGbHKOCDRET_44BADyuWg2 content esgSubNav
In This List

Sartorius to buy majority stake in Israel's Biological Industries

Blog

Insight Weekly: Banks brace for recession; Europe PE deal values soar; US solar imports rebound

Blog

Banking Essentials Newsletter: December 7th Edition

Blog

Banking Essentials Newsletter: December 7th Edition

Video

According to Market Intelligence, December 2022


Sartorius to buy majority stake in Israel's Biological Industries

Pharmaceutical equipment supplier Sartorius AG agreed to acquire just over 50% of the shares of Israeli cell culture media company Biological Industries Israel Beit Haemek Ltd. from its owners, Kibbutz Beit Haemek and private equity fund Fortissimo Capital, in a cash transaction worth approximately €45 million.

The deal also includes an option to acquire a further 20% of the shares within three years.

The transaction is set to be finalized by mid-December, subject to customary closing conditions.